Quoin Pharmaceuticals Q3 EPS $(0.97) Beats $(1.52) Estimate
Benzinga Newsdesk 13 hours ago
NewsEarningsEarnings Beats
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.52) by 36.18 percent. This is a 85.54 percent increase over losses of $(6.71) per share
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.52) by 36.18 percent. This is a 85.54 percent increase over losses of $(6.71) per share from the same period last year.